Itai Ashlagi and I received the NKR Terasaki Medical Innovation award Monday evening at the
American Transplant Congress meeting in Boston, for our work on kidney exchange algorithms for patient pools with highly sensitized patients.
"The Terasaki Medical Innovation Award will be presented annually to a medical professional who, through their pioneering work, has had a significant impact in advancing paired exchange transplantation and saving the lives of those facing kidney failure. "
Awards are nice for the recipients, but one can't help but be mpressed by the career of the scientist after whom the award is
named, UCLA's
Dr. Paul Ichiro Terasaki. Dr. Terasaki
pioneered the tests used today to determine immunocompatibility, and built a
business to make tools to implement those tests widely available.
Born in California in 1929, he and his family were interned with other Japanese-Americans during WWII. Later in life he
donated $50 Million to UCLA, which named their Life Sciences building after him.
In short, he has had a storied scientific and American career.
Also receiving an award Monday evening was the non-directed altruistic donor
Alexander Berger, about whom I blogged earlier:
A kidney donor argues that selling kidneys should be legal, after he published a NY Times op-ed to that effect. (He's a 2011 Stanford philosophy grad, and he apparently worked with
Debra Satz, although they disagree about whether kidney sales should be allowed.) Appropriately enough, he's currently working for an organization called
Give Well, which works to identify charities that are "cost-effective, underfunded, and outstanding." He gave well himself, and started a nonsimultaneous extended altruistic donor (NEAD) chain of the kind
NKR is famous for.
(I discussed the first NEAD chain
here, and have posted about them
frequently.)
The food was pretty good too.